This year APS will again award at least two grants in the amount of $20,000 each to those research proposals demonstrating the greatest merit and potential for success. This grant program has been established to fund research projects of doctorally-prepared investigators who have not yet attained NIH RO1 level funding. The program’s intent is to encourage research in pain that will add to the body of knowledge, and to allow investigators to develop pilot data that will aid them in securing additional major grant funding.
The application period has closed. Grant recipients will be announced in the fourth quarter.
Proposed research projects should be in one of the following five areas of inquiry.
To be eligible for an APS Future Leaders in Pain Research Grant, applicants must be
For additional information contact APS at 847-375-4715 or info@ampainsoc.org.
APS gratefully acknowledges Eli Lilly, Endo Pharmaceuticals Inc. and Purdue Pharma L.P. for their generous funding of the grants program.
APS Future Leaders in Pain Research Grants Program Review Committee:
Patrick M. Dougherty, PhD, Chair
Karen O. Anderson, PhD
Jim Campbell, MD
Michael Caterina, PhD
C. Richard Chapman, PhD
Robert R. Edwards, MD PhD
Gerald F. Gebhart, PhD
Michael Gold, PhD
Janean Holden, PhD RN FAAN
Jianren Mao, MD PhD
Gayle Page, RN DNSc
Barbara Rakel, PhD RN
George Wilcox, PhD